9-128945980-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_014908.4(DOLK):c.1324G>A(p.Ala442Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014908.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOLK | NM_014908.4 | c.1324G>A | p.Ala442Thr | missense_variant | 1/1 | ENST00000372586.4 | NP_055723.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOLK | ENST00000372586.4 | c.1324G>A | p.Ala442Thr | missense_variant | 1/1 | NM_014908.4 | ENSP00000361667 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251394Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135896
GnomAD4 exome AF: 0.000169 AC: 247AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.000169 AC XY: 123AN XY: 727234
GnomAD4 genome AF: 0.000177 AC: 27AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74458
ClinVar
Submissions by phenotype
DK1-congenital disorder of glycosylation Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 05, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 442 of the DOLK protein (p.Ala442Thr). This variant is present in population databases (rs143641133, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with DOLK-related conditions. ClinVar contains an entry for this variant (Variation ID: 464196). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 30, 2017 | The p.Ala442Thr variant in DOLK has not been previously reported in individuals with cardiomyopathy, but has been identified in 24/66724 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s143641133). Computational prediction tools and conservation analysis do not pro vide strong support for or against an impact to the protein. In summary, the cli nical significance of the p.Ala442Thr variant is uncertain. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 02, 2023 | The p.A442T variant (also known as c.1324G>A), located in coding exon 1 of the DOLK gene, results from a G to A substitution at nucleotide position 1324. The alanine at codon 442 is replaced by threonine, an amino acid with similar properties. This variant was reported in a sudden infant death case with limited clinical information provided (Neubauer J et al. Eur. J. Hum. Genet., 2017 04;25:404-409). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at